NASDAQ$HCAT
Health Catalyst Inc · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Health Catalyst reported strong financial results, exceeding revenue and Adjusted EBITDA guidance.
Health Catalyst reported a 24% increase in total revenue compared to the previous year. The company exceeded the midpoint of its quarterly guidance for both revenue and Adjusted EBITDA. Team member satisfaction scores continue to rank in the 96th percentile.
- Total revenue increased by 24% year-over-year.
- Technology revenue increased by 37% year-over-year.
- Professional services revenue increased by 8% year-over-year.
- Adjusted EBITDA improved by 86% year-over-year.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$55.8M
Revenue by segment
Health Catalyst · $55.8M total across 2 segments · Q1 2021
- Technology$33.8M+37.0%60.6%
- Professional Services$22M+7.8%39.4%
Forward guidance
For Q2 2021, Health Catalyst expects total revenue between $55.1 million and $58.1 million, and Adjusted EBITDA between $(4.8) million and $(2.8) million. For the full year 2021, the company expects total revenue between $228.1 million and $231.1 million, and Adjusted EBITDA between $(15.0) million and $(13.0) million.
Tailwinds
- Total revenue between $55.1 million and $58.1 million for Q2 2021.
- Adjusted EBITDA between $(4.8) million and $(2.8) million for Q2 2021.
- Total revenue between $228.1 million and $231.1 million for the full year 2021.
- Adjusted EBITDA between $(15.0) million and $(13.0) million for the full year 2021.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2021
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro